ORPP logo

Concepts in Vaccine Development. (Record no. 64711)

MARC details
000 -LEADER
fixed length control field 03819nam a22004453i 4500
001 - CONTROL NUMBER
control field EBC3042712
003 - CONTROL NUMBER IDENTIFIER
control field MiAaPQ
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240729124331.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d |
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr cnu||||||||
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240724s1996 xx o ||||0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9783110906660
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9783110148152
035 ## - SYSTEM CONTROL NUMBER
System control number (MiAaPQ)EBC3042712
035 ## - SYSTEM CONTROL NUMBER
System control number (Au-PeEL)EBL3042712
035 ## - SYSTEM CONTROL NUMBER
System control number (CaPaEBR)ebr10754877
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)922945714
040 ## - CATALOGING SOURCE
Original cataloging agency MiAaPQ
Language of cataloging eng
Description conventions rda
-- pn
Transcribing agency MiAaPQ
Modifying agency MiAaPQ
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number QR189.C66 1996eb
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Kaufmann, Stefan H. E.
245 10 - TITLE STATEMENT
Title Concepts in Vaccine Development.
250 ## - EDITION STATEMENT
Edition statement 1st ed.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Berlin/Boston :
Name of producer, publisher, distributor, manufacturer Walter de Gruyter GmbH,
Date of production, publication, distribution, manufacture, or copyright notice 1996.
264 #4 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice ©1996.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (608 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Intro -- 1. The Need for New Vaccines -- 1.1 Vaccines as Evolutionary Tools: The Virulence-Antigen Strategy -- Acknowledgements -- References -- 1.2 Economic Perspectives on Vaccine Needs -- Acknowledgments -- References -- 1.3 Future Immunization Strategies - Considerations from the Public Health View -- References -- 1.4 The New Pertussis Vaccines -- References -- 2. General Principles of Immunology -- 2.1 Basic Principles of Immunity Against Intracellular Bacteria and Protozoa -- Acknowledgements -- References -- 2.2 Viral Immunity and Vaccine Strategies -- Acknowledgements -- References -- 2.3 Broadly Reactive HLA Restricted T Cell Epitopes and Their Implications for Vaccine Design -- Acknowledgements -- References -- 2.4 Quantitative Considerations in the Design of Vaccination Strategies Against Pathogens Uniquely Susceptible to Cell-Mediated Attack -- References -- 2.5 The Impact of the Type 1 and Type 2 T Helper Cell Concept on Novel Vaccine Design with Emphasis on Protection Against Leishmania Parasites -- Acknowledgements -- References -- 3. General Principles of Vaccinology -- 3.1 Modern Adjuvants. Functional Aspects -- References -- 3.2 Biodegradable Microspheres as Vehicles for Antigens -- References -- 3.3 Peptide Based Vaccines -- References -- 3.4 Recombinant Bacteria as Vaccine Carriers of Heterologous Antigens -- References -- 3.5 Genetic Detoxification of Bacterial Toxins -- References -- 3.6 Recombinant Virus as Vaccination Carrier of Heterologous Antigens -- References -- 3.7 Naked DNA Vaccination -- References -- 3.8 Oral Vaccination, Mucosal Immunity and Oral Tolerance with Special Reference to Cholera Toxin -- Acknowledgements -- References -- 4. Specific Vaccination Strategies -- 4.1 Helicobacter pylori: Pathogenic Determinants and Strategies for Vaccine Design -- Acknowledgements -- References -- 4.2 Malaria Vaccination.
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note Acknowledgements -- References -- 4.3 Vaccination Against Schistosomiasis: Concepts and Strategies -- References -- 4.4 AIDS Vaccination -- References -- 4.5 Vaccination Therapy Against Autoimmune Diseases -- Acknowledgements -- References -- Contributors.
520 ## - SUMMARY, ETC.
Summary, etc. No detailed description available for "Concepts in Vaccine Development".
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note Description based on publisher supplied metadata and other sources.
590 ## - LOCAL NOTE (RLIN)
Local note Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vaccines.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunization.
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term Electronic books.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Kaufmann, Stefan H. E.
Title Concepts in Vaccine Development
Place, publisher, and date of publication Berlin/Boston : Walter de Gruyter GmbH,c1996
International Standard Book Number 9783110148152
797 2# - LOCAL ADDED ENTRY--CORPORATE NAME (RLIN)
Corporate name or jurisdiction name as entry element ProQuest (Firm)
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3042712">https://ebookcentral.proquest.com/lib/orpp/detail.action?docID=3042712</a>
Public note Click to View

No items available.

© 2024 Resource Centre. All rights reserved.